Skip to main content
[Preprint]. 2024 Mar 20:2024.03.18.585599. [Version 1] doi: 10.1101/2024.03.18.585599

Table 1.

SARS-CoV-3 Reagents and Sources

Reagent Description Source Catalogue Number Usage
TBS Tris Buffered Saline with Casein BioRad 1610782 DBS Elution
FLT Full Length Trimeric SARS-CoV-2 Spike MassBiologics N/A 8-Plex MIA/iACE2
FLS Full length SARS-CoV-2 Spike, His-Tag Native Antigen REC31868–100 8-Plex MIA
Spike Subunit 1 (S1) SARS-CoV-2 (2019-nCoV) Spike S1, His-Tag Sino Biological 40591-V08H 8-Plex MIA
RBD SARS-CoV-2 Stable RBD, Thrombin-His MassBiologics N/A 8-Plex MIA
Nucleocapsid (N) 2019-nCoV Nucleocapsid Protein, His tag SinoBiological 40588-V08B 8-Plex MIA
Nucleocapsid (N-NA) SARS-CoV-2 Nucleoprotein, His-Tag (E. coli) Native Antigen REC31812–100 8-Plex MIA
Nucleocapsid (NHT) SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein (His tag) Sino Biological 0588-V07E 8-Plex MIA
Internal Control (IC) Mouse anti-Human IgG3 Secondary Antibody ThermoFisher MA1–83242 8-Plex MIA
WT sRBD SARS (WA1/2020) RBD, Thrombin-His MassBiologics N/A iACE2
hACE2 Biotinylated ACE2 Wadsworth Center Protein Core N/A iACE2
CC12.3 Human Mab RBD-A WT D614G Scripps N/A iACE2/RVP
RVP-702L WT D614G Strain Reporter Virus Particles Integral Molecular CL-275A RVP
293-hsACE2 Cells 293T cells expressing human ACE2 receptor Integral Molecular TA-060520-MC RVP